Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34⁺ progenitor cells

References

• Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Pena J, Solana R, Coligan JE (2002). Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol. 38: 637–60.
   PubMed Web of Science ®Google Scholar
• Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998). Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187: 813–818.
   PubMed Web of Science ®Google Scholar
• Briard D, Brouty-Boye D, Azzarone B, Jasmin C (2002). Fibroblasts from human spleen regulate NK cell differentiation from blood CD34(+) progenitors via cell surface IL-15. J Immunol. 168: 4326–4332.
   PubMed Web of Science ®Google Scholar
• Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE (1997). NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med. 185: 795–800.
   PubMed Web of Science ®Google Scholar
• Byrd A, Hoffmann SC, Jarahian M, Momburg F, Watzl C (2007). Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44. PLoS One. 2: e1339.
   PubMedGoogle Scholar
• Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith K A, Ritz J (1990). Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med. 171: 1509–1526.
   PubMed Web of Science ®Google Scholar
• Carayol G, Robin C, Bourhis JH, Bennaceur-Griscelli A, Chouaib S, Coulombel L, Caignard A (1998). NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur J Immunol. 28: 1991–2002.
   PubMed Web of Science ®Google Scholar
• Colucci F, Caligiuri MA, Di Santo JP (2003). What does it take to make a natural killer? Nat Rev Immunol. 3: 413–425.
   PubMed Web of Science ®Google Scholar
• Condiotti R, Zakai YB, Barak V, Nagler A (2001). Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Exp Hematol. 29: 104–113.
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Caligiuri MA (2001). The biology of human natural killer-cell subsets. Trends Immunol. 22: 633–640.
   PubMed Web of Science ®Google Scholar
• Farag SS Caligiuri MA (2006). Human natural killer cell development and biology. Blood Rev. 20: 123–137.
   PubMed Web of Science ®Google Scholar
• Figueiredo C, Seltsam A, Blasczyk R (2009). Permanent silencing of NKG2A expression for cell-based therapeutics. J Mol Med. 87: 199–210.
   PubMed Web of Science ®Google Scholar
• Garcia-Lora A, Algarra I, Garrido F (2003). MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol. 195: 346–355.
   PubMed Web of Science ®Google Scholar
• Grzywacz B, Kataria N, Sikora M, Oostendorp RA, Dzierzak EA, Blazar BR, Miller JS, Verneris MR (2006). Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood. 108: 3824–3833.
   PubMed Web of Science ®Google Scholar
• Hallett WH Murphy WJ (2006). Positive and negative regulation of Natural Killer cells: therapeutic implications. Semin Cancer Biol. 16: 367–382.
   PubMed Web of Science ®Google Scholar
• Iizuka K, Chaplin DD, Wang Y, Wu Q, Pegg LE, Yokoyama WM, Fu YX (1999). Requirement for membrane lymphotoxin in natural killer cell development. Proc Natl Acad Sci U S A. 96: 6336–6340.
   PubMed Web of Science ®Google Scholar
• Kao IT, Yao CL, Kong ZL, Wu ML, Chuang TL, Hwang SM (2007). Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells. Stem Cells Dev. 16: 1043–1051.
   PubMed Web of Science ®Google Scholar
• Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M, Syono Y, Ota S, Kondo T, Asaka M, Imamura M (2007). Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia. 21: 2103–2108.
   PubMed Web of Science ®Google Scholar
• Lanier LL (2008). Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 9: 495–502.
   PubMed Web of Science ®Google Scholar
• Lanier LL, Testi R, Bindl J, Phillips JH (1989). Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 169: 2233–2238.
   PubMed Web of Science ®Google Scholar
• Lewis ID Verfaillie CM (2000). Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood. Exp Hematol. 28: 1087–1095.
   PubMed Web of Science ®Google Scholar
• Miller JS Mccullar V (2001). Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 98: 705–713.
   PubMed Web of Science ®Google Scholar
• Moore KA, Ema H Lemischka IR (1997). In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood. 89: 4337–4347.
   PubMed Web of Science ®Google Scholar
• Moretta L, Biassoni R, Bottino C, Cantoni C, Pende D, Mingari MC, Moretta A (2002). Human NK cells and their receptors. Microbes Infect. 4: 1539–1544.
   PubMed Web of Science ®Google Scholar
• Mrozek E, Anderson P,Caligiuri MA (1996). Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 87: 2632–2640.
   PubMed Web of Science ®Google Scholar
• Nagler A, Lanier LL, Phillips JH (1990). Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J Exp Med. 171: 1527–1533.
   PubMed Web of Science ®Google Scholar
• Orange JS Ballas ZK (2006). Natural killer cells in human health and disease. Clin Immunol. 118: 1–10.
   PubMed Web of Science ®Google Scholar
• Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL (2002). Viral evasion of natural killer cells. Nat Immunol. 3: 1006–1012.
   PubMed Web of Science ®Google Scholar
• Papamichail M, Perez SA, Gritzapis AD Baxevanis CN (2004). Natural killer lymphocytes: biology, development, and function. Cancer Immunol Immunother. 53: 176–186.
   PubMed Web of Science ®Google Scholar
• Robertson MJ Ritz J (1990). Biology and clinical relevance of human natural killer cells. Blood. 76: 2421–2438.
   PubMed Web of Science ®Google Scholar
• Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J (1992). Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med. 175: 779–788.
   PubMed Web of Science ®Google Scholar